Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53

Benzinga Newsdesk www.benzinga.com Positive 63.5%

Neg 0% Neu 0% Pos 63.5%

Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.